Delivery Order SPE2DB22D1002-SPE2DB24FLFZ5
Award Date
8/5/24
Potential Completion Date
8/6/24
Potential Value
$3.6K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to Amerisourcebergen Drug Corporation's Corporate Office division is for the delivery of the pharmaceutical product STELARA 45 MG/0.5 ML SYRINGE 0.5ML. The contract, valued at $3,561.86, was issued by the Defense Logistics Agency (DLA) as a Firm Fixed Price delivery order. It has a completion date of July 16, 2024. Amerisourcebergen is a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, particularly the Department of...
This federal contract award is a delivery order valued at $23,969.88, issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of STELARA 90 MG/ML syringes, with an ultimate completion date of August 7, 2024. The contract is a firm fixed-price arrangement and is not set aside for any specific business type. Amerisourcebergen Drug Corp, through its Corporate Office division, has been awarded numerous federal...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office division. The $4,366.28 firm-fixed-price delivery order is for the supply of STELARA 45 MG/0.5 ML syringes, a specialty pharmaceutical product. The contract has a completion date of July 19, 2024. AmerisourceBergen, a major pharmaceutical distributor, holds several Indefinite Delivery Contracts (IDCs) with the DLA and other agencies, valued up to $999,999,999, to provide...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $46,337.92 firm fixed-price delivery order is for the supply of STELARA 90 MG/ML syringe, a specialty medication. The contract has an ultimate completion date of October 18, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary...
This federal contract award, valued at $3,561.86, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp. for the supply of STELARA 45 MG/0.5 ML SYRINGE 0.5ML, a pharmaceutical product. The contract is a firm fixed-price delivery order with an ultimate completion date of August 2, 2024. Amerisourcebergen, a major pharmaceutical distributor, has been awarded this contract to provide the specified drug to support the healthcare needs of military personnel, veterans, and...
This federal contract award is for the delivery of STELARA 90 MG/ML SYRINGEML, a specialty pharmaceutical product, to the Medical Supply Chain, a component of the Defense Logistics Agency (DLA). The contract was awarded to the prime contractor, AmerisourceBergen Drug Corp, Corporate Office Division, a major pharmaceutical distributor in the United States. The contract has a ceiling value of $7,154.84 and is a firm fixed-price delivery order with a period of performance through July 23, 2024....
This federal contract award is for the delivery of STELARA 90 MG/ML SYRINGEML, a pharmaceutical product, to the Medical Supply Chain division of the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp's Corporate Office division on August 15, 2024 as a Delivery Order with a Firm Fixed Price of $21,404.97 and a ceiling value of $21,404.97. The contract has an ultimate completion date of August 16, 2024 and does not utilize a set-aside. Amerisourcebergen Drug...
This federal contract award, valued at $30,518.55, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office division. The contract is for the delivery of STELARA 90 MG/ML SYRINGEML, a specialty pharmaceutical product, with an ultimate completion date of August 21, 2024. The contract is a Delivery Order on a Firm Fixed Price basis, with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor, has been awarded numerous...
This federal contract award is for the delivery of STELARA 90 MG/ML syringes to the Defense Logistics Agency (DLA), a defense agency. The $46,728.95 firm-fixed-price contract was awarded on May 29, 2024 to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distributor. The contract has an ultimate completion date of May 30, 2024 and is not associated with a set-aside designation. Amerisourcebergen holds two Indefinite Delivery Contracts (IDCs) with the federal...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office Division. The $18,598.68 fixed-price contract is for the supply of 4,565,510,439 units of the pharmaceutical product STELARA 45 MG/0.5 ML SYRINGE 0.5ML. The order has an ultimate completion date of August 21, 2024 and was awarded on August 20, 2024. AmerisourceBergen, a major pharmaceutical distributor, has been awarded numerous federal contracts by defense and civilian...